Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial

Alexandra J. Lansky, Andreas Baumbach, Andrzej Ochała et al.|The Lancet|2018

Cited by 61